Inari Medical Quote - NARI

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

51.72

Bid

51.70

Ask

51.84

Volume

224,557

50.77 Day's Range 51.985

36.73 52 Week Range 67.13

Market Cap

3.028B

Previous Close

51.55

Open

51.51

Last Trade

51.68

Last Trade Time

12:51:19

Financial Volume

US$ 11,582,894

VWAP

51.5811

Average Volume (3m)

850,855

Shares Outstanding

58,544,158

Dividend Yield

PE Ratio

-1,846.59

Earnings Per Share (EPS)

-0.03

Revenue

493.63M

Net Profit

-1.64M

Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from venous diseases. Its product portfolio includes ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTreive... Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from venous diseases. Its product portfolio includes ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTreiver product is used for the treatment of pulmonary embolism. Geographically, the company has its presence across the United States. Show more

Sector

Surgical,med Instr,apparatus

Industry

Surgical,med Instr,apparatus

Website

www.inarimedical.com

Headquarters

Wilmington, Delaware, USA

Founded

Inari Medical Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker NARI. The last closing price for Inari Medical was US$51.55. Over the last year, Inari Medical shares have traded in a share price range of US$ 36.73 to US$ 67.13.

Inari Medical currently has 58,544,158 shares outstanding. The market capitalization of Inari Medical is US$3.02 billion. Inari Medical has a price to earnings ratio (PE ratio) of -1846.59.

Form 4 - Statement of changes in beneficial ownership of securities

Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.

IRVINE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering...

PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism

IRVINE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.62	1.2133072407	51.1	53.065	50.4	553751	51.70441201	CS
4	0.16	0.310318076028	51.56	53.67	47.96	730527	51.0282233	CS
12	7.32	16.4864864865	44.4	53.67	39.76	850855	46.23335424	CS
26	1.67	3.33666333666	50.05	59.9	39.76	843878	47.45371069	CS
52	-9.28	-15.2131147541	61	67.13	36.73	946408	48.11268297	CS
156	-26.99	-34.2904332359	78.71	100	36.73	793258	59.83658933	CS
260	10.42	25.2300242131	41.3	127.42	36.73	694758	65.57556173	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CYCNCyclerion Therapeutics Inc	US$ 7.2136 (348.05%)	115.72M
SMXSMX Security Matters Public Company	US$ 0.512549 (163.12%)	457.13M
CNEYCN Energy Group Inc	US$ 0.593026 (87.90%)	155.23M
SRMSRM Entertainment Inc	US$ 1.1208 (77.88%)	133.89M
HTOOFusion Fuel Green PLC	US$ 0.559 (75.79%)	267.09M
RLMDRelmada Therapeutics Inc	US$ 0.643 (-76.79%)	14.06M
MIGIMawson Infrastructure Group Inc	US$ 0.8422 (-55.91%)	10.9M
MONDMondee Holdings Inc	US$ 0.1998 (-32.29%)	2.58M
ORISOriental Rise Holdings Ltd	US$ 8.48 (-29.04%)	507.23k
FGLFounder Group Limited	US$ 2.95 (-27.70%)	9.79M
SMXSMX Security Matters Public Company	US$ 0.512549 (163.12%)	457.13M
SVMHSRIVARU Holding Ltd	US$ 0.0267 (21.36%)	438.3M
HTOOFusion Fuel Green PLC	US$ 0.559 (75.79%)	267.09M
CNEYCN Energy Group Inc	US$ 0.593026 (87.90%)	155.23M
SRMSRM Entertainment Inc	US$ 1.1208 (77.88%)	133.89M